§ 21-2A-06.1
129 words·~1 min read·
/md/health-general/21-2a-06-1·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
§21–2A–06.1.
(a)Naloxone medication data:
(1)Are confidential and privileged, and not subject to discovery, subpoena, or other means of legal compulsion in civil litigation;
(2)Are not public records; and
(3)Except as provided in subsection
(b)of this section or as otherwise by law, may not be disclosed to any person.
(1)The Program shall disclose naloxone medication data, in accordance with regulations adopted by the Secretary, for public health surveillance, research, analysis, public reporting, and education after redaction of all information that could identify a patient, prescriber, dispenser, or any other individual.
(2)The Secretary may require submission of an abstract explaining the scope and purpose of the research, analysis, public reporting, or education before disclosing naloxone medication data under paragraph
(1)of this subsection.